BDBM620751 (8-syn)-3-(6-chloro-2-{[1-(2- hydroxy-2-methylpropyl)- 1H-pyrazol-4-yl]amino} quinazolin-7-yl)-8-methyl- 3-azabicyclo[3.2.1]octan-8-ol::US20230303540, Example Ex-3.32

SMILES CC(C)(O)Cn1cc(Nc2ncc3cc(Cl)c(cc3n2)N2C[C@@H]3CC[C@H](C2)[C@]3(C)O)cn1

InChI Key InChIKey=FFPOYHUZXJZYGJ-MICWEPACSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 620751   

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM620751((8-syn)-3-(6-chloro-2-{[1-(2- hydroxy-2-methylprop...)
Affinity DataIC50:  0.393nMAssay Description:The LRRK2 kinase activity reported herein as IC50 values was determined with LanthaScreen technology from Life Technologies Corporation (Carlsbad, CA...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent